Nasdaq: ADRX · Listed Sep 25, 2026
ADARx Pharmaceuticals IPO
IPO price
$17.00
ADARx Pharmaceuticals (ADRX) priced its IPO at $17.00 a share and has traded on Nasdaq since Sep 25, 2026.
ADRX today$12.82-24.59%since IPO15-min delayed · as of 7:30:02 PM EST on Nov 18, 2026
See the ADRX quoteFirst trading day · Sep 25, 2026
- IPO price
- $17.00
- the top of the range of $15 to $17
- First trade
- $22.10
- +30.00% from the IPO price
- First-day last trade
- $19.19
- +12.88% from the IPO price, regular session
- Raise
- $446.25M
- before the underwriters' option
These numbers are from the first trading day, Sep 25, 2026.
How ADRX did against the market
ADRX against the market, from its first trade at 12:10 ET to the last trade of the session.
- ADRX from its first trade
- -13.17%
- Against the market (QQQ)
- -13.0 pts
ADRX fell 13.2% from its first trade to the last trade of the session. That is 13.0 points worse than the market.
Same-day moves do not show that ADRX caused them. The market is QQQ, the Nasdaq-100 ETF.
The debut race
ADRX against other big listings, as the percent change from each stock's own IPO price.
The first 30 trading days. Each point is the last regular-session trade of a day.
The first trading day.
The first trading day.
The IPO scoreboard
ADRX against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.
| IPO | Raised | First trade | Day 1 close | Day 1 close, as a bar | Day 5 | Day 30 |
|---|---|---|---|---|---|---|
| ADARx Pharmaceuticals '26 | $446.25M | +30.00% | +12.88% | +14.00% | -22.47% | |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% | |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% | |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% | |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% | |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% | |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |
Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.
The offering
The ADARx Pharmaceuticals IPO offers 26.25M shares to raise $446.25M, before any underwriters' option.
- Expected price range
- $15 to $17
- IPO price
- $17.00
- Shares offered
- 26.25M
- Money raised
- $446.25M
- Listing date
- Sep 25, 2026
- Exchange
- Nasdaq
- Security
- Ordinary Shares
Money raised, against the largest IPOs
- Alibaba '14$21.77B
- Facebook '12$18.41B
- Rivian '21$11.93B
- Uber '19$8.1B
- Arm '23$5.23B
- ADARx Pharmaceuticals$446.25M
Where ADRX ranks
ADARx Pharmaceuticals's market cap against the largest US-listed companies.
Market cap, against the largest US-listed companies
- AAPL$5.12T
- MSFT$3.77T
- NVDA$3.65T
- GOOGL$3.47T
- AMZN$2.9T
- TSM$1.88T
- AVGO$1.69T
- META$1.58T
- TSLA$1.52T
- BRK.B$1.22T
- ADRX$1.42B
Filings and the company
What ADARx Pharmaceuticals has disclosed to the SEC, and the basic facts about the listing.
8-K filings
Material events that ADARx Pharmaceuticals discloses to the SEC on Form 8-K.
- Investor presentationNov 12, 2026
On November 12, 2026, the Company updated its corporate presentation for use in meetings with investors, analysts and others from time to time and made the presentation available on the investor relations page of the Company's website at https://investors.adarx.com/.
- Underwriting agreementSep 28, 2026
J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, TD Securities (USA) LLC, UBS Securities LLC and LifeSci Capital LLC acted as placement agents for the Private Placement, and the Company paid a placement agent fee equal to 2.0% of the total purchase price of the shares sold in the Private Placement.
About ADARx Pharmaceuticals
Adarx Pharmaceuticals Inc is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Its pipeline includes three clinical-stage programs and two advanced preclinical programs. The three hepatic-targeted programs are agazisiran, onvuzosiran, and ADX-626, while the two extrahepatic-targeted programs are ADX-077 and ADX-199.
- Ticker
- ADRX
- Exchange
- Nasdaq
- Market
- stocks
- Type
- CS
- Currency
- USD
- Industry
- PHARMACEUTICAL PREPARATIONS
- Listed
- Sep 25, 2026
- Security
- Ordinary Shares
Frequently asked questions
What was the ADARx Pharmaceuticals IPO price?
$17.00 a share.
When did ADARx Pharmaceuticals go public?
ADARx Pharmaceuticals listed on Nasdaq on Sep 25, 2026 under the ticker ADRX.
How much did the ADARx Pharmaceuticals IPO raise?
$446.25M, before any underwriters' option.
How did ADARx Pharmaceuticals open on its first day?
ADRX first traded at $22.10, +30.00% from the IPO price of $17.00.
How did ADRX close on its first day?
Its last regular-session trade was $19.19, +12.88% from the IPO price of $17.00.
What was the ADRX first-day trading range?
$19.00 to $23.21 in the regular session.
How many ADRX shares traded on the first day?
4.13M shares in the regular session.
How many shares did ADARx Pharmaceuticals sell in its IPO?
26.25M shares.
How did ADRX do against the market on its first day?
ADRX fell 13.2% from its first trade to the last trade of the session. That is 13.0 points worse than the market (QQQ, the Nasdaq-100 ETF).
What exchange is ADRX listed on?
ADARx Pharmaceuticals lists on Nasdaq under the ticker ADRX.
Build with Massive
Get the ADRX data behind this page
| What the page shows | Endpoint |
|---|---|
| Offering terms and dates | /vX/reference/ipos |
| Price | /v3/snapshot |
| Chart, VWAP, and the market comparison | /v2/aggs/ticker/ADRX/range/5/minute |
| Market cap | /v3/reference/tickers/ADRX |
| News | /v2/reference/news |
| Filings | /vX/disclosures |
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.